Cardiex Share Price and Company Fundamentals



Price
$0.3
Change
-0.010 (-3.226%)
52 week
0.25 - 0.77

Last traded: Today at 3:58 AM

CardieX Limited designs, manufactures, and markets medical devices for use in cardiovascular health management in the Americas, Europe, and the Asia Pacific. The company undertakes contracts with pharmaceutical companies for the use of SphygmoCor XCEL devices; provides lab and data management services for clinical trials comprising end-to-end service that delivers clean datasets to study sponsors. It also develops home vascular health solutions, remote patient monitoring, decentralized clinical trials and solutions wearables, and medical health apps under the CONNEQT name, as well as CONNEQT Pulse device, a home-based heart health vital signs monitoring system, that measures central blood pressure, arterial waveforms, and various other proprietary arterial health parameters through its SphygmoCor technology. The company serves hospitals, clinics, research institutions and pharmaceutical companies. It has strategic collaboration agreement with LifeQ, Inc for wearable devices. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is based in Sydney, Australia.

Key Metrics

PE ratio

-

PB ratio

5.87

Dividend yield

0.00%

Beta

2.03

Market cap

-

Enterprise value

-

Company profile

Primary activitiesThe development and marketing of the SphygmoCor device used for cardiovascular patient assessment and management.
Industry / SectorMedical Devices / Healthcare
Websitehttps://cardiex.com
Mailing address55 Lime Street Suite 301 Level 3 Sydney NSW 2000 Australia
Phone / Fax61 2 9874 8761 /
Share registryAUTOMIC REGISTRY SERVICES

Dividends

More: Cardiex Dividend history, yield and payout ratio

Dividend yield

0.00%

Dividend amount

$0.00

Payout ratio

0.00%

Cardiex paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.CDX dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

CDX's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Oct 2022, following are the company executives and directors listed on Cardiex.

NameTitleAgeTotal Pay
Mr. Niall Charles Edgar Cairns ACA, B.Ec, FAICDCo-Founder & Exec. Chairman57260k
Mr. Craig R. Cooper BEC, L.L.B.Co-Founder, CEO, MD & Exec. Director716.42k
Mr. Jarrod Travers White B.Bus, C.A., CA, CTACFO, Joint Company Sec. & Exec. Director116.5k
Mr. Chris DaxVP of Operations & Pres of ATCOR Medical
Carol TargosAccounts Mang.
Ahmad QasemChief Science & Research Officer
Mr. Antony SloanGlobal Head of Marketing & Communications
Mr. ZiHan LinVP of Corp. & Bus. Devel.
Mr. Douglas T. KurschinskiExec. VP & Head of Global Sales for AtCor Medical Division
Dr. Steven KestenChief Medical Officer63

Profitability and management effectiveness

Profit margin

-249.25%

Operating margin

-254.02%

Return on assets

-61.56%

Return on equity

-154.19%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Cardiex is and its enterprise value is .

The CDX's stocks Beta value is 2.03 making it 103% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Cardiex (CDX)

Cardiex (ASX:CDX) Frequently Asked Questions

1. What is Cardiex's Stock Symbol?

Cardiex trades on ASX under the ticker symbol "CDX".

2. What is Cardiex's stock price today?

One share of CDX stock can currently be purchased for approximately $0.3.

3. How can I contact Cardiex?

Cardiex's mailing address is 55 Lime Street Suite 301 Level 3 Sydney NSW 2000 Australia. The company can be reached via phone at 61 2 9874 8761.

4. What is Cardiex's official website?

The official website of Cardiex is https://cardiex.com.

5. Which share registry manages Cardiex's stock?

Cardiex's stock is managed by AUTOMIC REGISTRY SERVICES.